1. Home
  2. VRCA vs FLNA Comparison

VRCA vs FLNA Comparison

Compare VRCA & FLNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Verrica Pharmaceuticals Inc.

VRCA

Verrica Pharmaceuticals Inc.

HOLD

Current Price

$5.60

Market Cap

87.5M

Sector

Health Care

ML Signal

HOLD

FLNA

Filana Therapeutics Inc. Common Stock

N/A

Current Price

$1.63

Market Cap

96.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VRCA
FLNA
Founded
2013
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
87.5M
96.1M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
VRCA
FLNA
Price
$5.60
$1.63
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$17.00
N/A
AVG Volume (30 Days)
91.9K
326.8K
Earning Date
05-12-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$35,577,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$92.12
N/A
P/E Ratio
N/A
N/A
Revenue Growth
370.22
N/A
52 Week Low
$0.39
$1.62
52 Week High
$9.82
$2.03

Technical Indicators

Market Signals
Indicator
VRCA
FLNA
Relative Strength Index (RSI) 51.38 31.04
Support Level $5.18 N/A
Resistance Level $6.48 $1.79
Average True Range (ATR) 0.48 0.09
MACD 0.09 -0.01
Stochastic Oscillator 73.23 5.26

Price Performance

Historical Comparison
VRCA
FLNA

About VRCA Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.

Share on Social Networks: